Is 11C-choline the Most Appropriate Tracer for Prostate Cancer? For

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2004 Apr 3

PMID 15060753

Citations 3

Authors

Ferruccio Fazio

Maria Picchio

Cristina Messa

Affiliations

Soon will be listed here.

Citing Articles

Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.

Panebianco V, Barchetti F, Musio D, De Felice F, Proietti C, Indino E Biomed Res Int. 2014; 2014:827265.

PMID: 24757679 PMC: 3971570. DOI: 10.1155/2014/827265.

Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET.

Dunphy M, Lewis J J Nucl Med. 2009; 50 Suppl 1:106S-21S.

PMID: 19380404 PMC: 2963172. DOI: 10.2967/jnumed.108.057281.

Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?.

Alavi A, Basu S Eur J Nucl Med Mol Imaging. 2008; 35(8):1554-9.

PMID: 18594816 DOI: 10.1007/s00259-008-0813-2.

References

Thomas C, Bradshaw P, Pollock B, Montie J, Taylor J, Thames H . Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy. J Clin Oncol. 2003; 21(9):1715-21. DOI: 10.1200/JCO.2003.05.138. View

Gittes R . Carcinoma of the prostate. N Engl J Med. 1991; 324(4):236-45. DOI: 10.1056/NEJM199101243240406. View

Wawroschek F, Vogt H, Wengenmair H, Weckermann D, Hamm M, Keil M . Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int. 2003; 70(4):303-10. DOI: 10.1159/000070140. View

Hofer C, Laubenbacher C, Block T, Breul J, Hartung R, Schwaiger M . Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur Urol. 1999; 36(1):31-5. DOI: 10.1159/000019923. View

de Jong I, Pruim J, Elsinga P, Vaalburg W, Mensink H . Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. J Nucl Med. 2003; 44(3):331-5. View

Rosenthal D . Radiologic diagnosis of bone metastases. Cancer. 1997; 80(8 Suppl):1595-607. DOI: 10.1002/(sici)1097-0142(19971015)80:8+<1595::aid-cncr10>3.3.co;2-z. View

Picchio M, Landoni C, Messa C, Gianolli L, Matarrese M, De Cobelli F . Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer. AJR Am J Roentgenol. 2002; 179(2):482-4. DOI: 10.2214/ajr.179.2.1790482. View

de Jong I, Pruim J, Elsinga P, Vaalburg W, Mensink H . 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol. 2003; 44(1):32-8; discussion 38-9. DOI: 10.1016/s0302-2838(03)00207-0. View

Roivainen A, Forsback S, Gronroos T, Lehikoinen P, Kahkonen M, Sutinen E . Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography. Eur J Nucl Med. 2000; 27(1):25-32. DOI: 10.1007/pl00006658. View

10.

Dimitrakopoulou-Strauss A, Strauss L . PET imaging of prostate cancer with 11C-acetate. J Nucl Med. 2003; 44(4):556-8. View

11.

Kotzerke J, Prang J, Neumaier B, Volkmer B, Guhlmann A, Kleinschmidt K . Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med. 2000; 27(9):1415-9. DOI: 10.1007/s002590000309. View

12.

Silverman J, Krebs T . MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. AJR Am J Roentgenol. 1997; 168(2):379-85. DOI: 10.2214/ajr.168.2.9016212. View

13.

Fricke E, Machtens S, Hofmann M, van den Hoff J, Bergh S, Brunkhorst T . Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients. Eur J Nucl Med Mol Imaging. 2003; 30(4):607-11. DOI: 10.1007/s00259-002-1104-y. View

14.

Moul J . Prostate specific antigen only progression of prostate cancer. J Urol. 2000; 163(6):1632-42. View

15.

DeGrado T, Baldwin S, Wang S, Orr M, Liao R, Friedman H . Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. J Nucl Med. 2001; 42(12):1805-14. View

16.

Hara T, Kosaka N, Shinoura N, Kondo T . PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med. 1997; 38(6):842-7. View

17.

Coleman , DeGrado , Wang , Baldwin , ORR , Reiman . 9:30-9:45. Preliminary Evaluation of F-18 Fluorocholine (FCH) as a PET Tumor Imaging Agent. Clin Positron Imaging. 2001; 3(4):147. DOI: 10.1016/s1095-0397(00)00059-5. View

18.

Hricak H, Schoder H, Pucar D, Lis E, Eberhardt S, Onyebuchi C . Advances in imaging in the postoperative patient with a rising prostate-specific antigen level. Semin Oncol. 2003; 30(5):616-34. DOI: 10.1016/s0093-7754(03)00359-2. View

19.

Sutinen E, Nurmi M, Roivainen A, Varpula M, Tolvanen T, Lehikoinen P . Kinetics of [(11)C]choline uptake in prostate cancer: a PET study. Eur J Nucl Med Mol Imaging. 2003; 31(3):317-24. DOI: 10.1007/s00259-003-1377-9. View

20.

Hara T . 11C-choline and 2-deoxy-2-[18F]fluoro-D-glucose in tumor imaging with positron emission tomography. Mol Imaging Biol. 2003; 4(4):267-73. DOI: 10.1016/s1536-1632(02)00015-x. View